Evidence map›Paper›PMID 20795695›Full record

ArticleThe journal of physical chemistry. B2010

Simulation of two-dimensional ultraviolet spectroscopy of amyloid fibrils.

Jun Jiang, Darius Abramavicius, Cyril Falvo, Benjamin M Bulheller, Jonathan D Hirst, Shaul Mukamel

Abstract read
In one paragraph

Article in The journal of physical chemistry. B, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jun JiangChemistry Department, University of California Irvine, Irvine, California, USA.
Darius Abramavicius
Cyril Falvo
Benjamin M Bulheller
Jonathan D Hirst
Shaul Mukamel

Funding

Multidimensional Femtosecond Correlation Spectroscopic Probes of BiomoleculesR01GM059230 · NIGMS · UNIVERSITY OF ROCHESTER · PI MUKAMEL, SHAUL · 2001 to 2013
$3.2M
Developing 2D UV/vis spectroscopy tools to study biomolecular recognitionRC1GM091364 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI MUKAMEL, SHAUL, ROMESBERG, FLOYD E. · 2009 to 2010
$949k
NIGMS NIH HHS GM059230NIGMS NIH HHS R01 GM059230NIGMS NIH HHS RC1 GM091364
6 · The paper itself

Abstract

Revealing the structure and aggregation mechanism of amyloid fibrils is essential for the treatment of over 20 diseases related to protein misfolding. Coherent two-dimensional (2D) infrared spectroscopy is a novel tool that provides a wealth of new insight into the structure and dynamics of biomolecular systems. Recently developed ultrafast laser sources are extending multidimensional spectroscopy into the ultraviolet (UV) region, and this opens up new opportunities for probing fibrils. In a simulation study, we show that 2DUV spectra of the backbone of a 32-residue β-amyloid (Aβ(9-40)) fibril associated with Alzheimer's disease and two intermediate prefibrillar structures carry characteristic signatures of fibril size and geometry that could be used to monitor its formation kinetics. The dependence of these signals on the fibril size and geometry is explored. We demonstrate that the dominant features of the β-amyloid fibril spectra are determined by intramolecular interactions within a single Aβ(9-40), and intermolecular interactions at the "external interface" have clear signatures in the fine details of these signals.

Indexed as

Molecular Dynamics SimulationAbsorptionAmino Acid MotifsAmyloid beta-PeptidesCircular DichroismKineticsPeptide FragmentsProtein ConformationSpectrophotometry, UltravioletAmyloid beta-Peptidesamyloid beta-protein (1-40)Peptide Fragments

Identifiers

PMID20795695
PMCPMC2953465

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.